Abstract
Sir.—Demidovich et al1recently published the results of a study comparing penicillin, erythromycin, and cephalexin therapies for impetigo. This study has to be praised, since a lot of confusion still exists with regard to childhood impetigo. Two of their conclusions were thatStaphylococcus aureuswas the most common cause of impetigo in children in their population and that penicillin is an inadequate treatment for this infection. Sixteen months earlier, I and a coauthor published our results of a study comparing amoxicillin with augmentin for the treatment of nonbullous impetigo.2In our population in southern Israel,S aureuswas isolated from 100% of the patients, while additional streptococci were isolated from 29%. All 51 isolates ofS aureuswere resistant to penicillin; treatment failure was observed in five (20%) of 25 patients who received amoxicillin compared with none of those who received augmentin. Our conclusions, as follows, were
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
